Effect of the anti-estrogen, nafoxidine, on nzb/w autoimmune disease
β Scribed by Madeleine Duvic; Alfred D. Steinberg; Lynell W. Klassen
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 335 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The novel anti-estrogen EM-800 and medroxyprogesterone acetate (MPA) inhibit estrone (E 1 )-stimulated growth of dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in a rat model. After 65 days, ovariectomy (OVX) decreased total tumor area to 9.6 Ψ 3.9% of initial size, while E 1 (1.0 Β΅g, s.c.,
The effects of the novel anti-estrogen EM-343 on the growth of 2 hormone-responsive human breast cancer tumors have been examined in athymic nude mice. At the low daily dose of 5 g, EM-343 administered subcutaneously for 6 months completely blocked the stimulatory effect of endogenous estrogens on t
## LETTERS cultured with CsA, but can be partially protected from the toxic effects of the drug by either removing Ca2' from the growth medium or co-treating the cultured cells with calcium channel blockers (7). A unifying hypothesis is that activation of Na+/K+-ATPase by the Ca2+-regulated phosp